Legalize
Legalize / Česká republika / Vyhláška

Vyhláška Ministerstva zdravotnictví, kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek

Typ Vyhláška
Publikace 1997-03-28
Naposledy aktualizováno 2004-02-01
Stav Platný
Zdroj e-Sbírka
článků 2
Historie novel JSON API
224 G04BX jiná urologika, k léčbě benigní hyperplasie prostaty p.o.
224.1 G04CA01 alfuzosin p.o. 7.5 MG 20,00 L/URN
224.2 G04CA01 alfuzosin (SR nebo retardované formy) p.o. 10 MG 20,00 L/URN
224.3 G04CA02 tamsulosin p.o. 0.4 MG 20,00 L/URN
224.4 G04CA03 terazosin p.o. 5 MG 16,80 L/URN
44311 KORNAM 2 MG por tbl nob30x2mg LEK SLO
44312 KORNAM 5 MG por tbl nob 30x5mg LEK SLO
224.5 G04CB01 finasterid p.o. 5 MG 20,00 L/URN
81493 FINEX por tbl flm 100x5mg GEA DK
81491 FINEX por tbl flm 30x5mg GEA DK
81492 FINEX por tbl flm 50x5mg GEA DK
224.6 G04CX01 extrakt Pyg. africanum p.o. 2 DF 16,00 L/URN
224.7 G04CX02 extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 2 a víckrát denně) p.o. 2 DF 16,00 L/URN
57897 SPALDA SABAL 160 MG cps 120x160mg KKA D
57898 SPALDA SABAL 160 MG cps 200x160mg KKA D
57896 SPALDA SABAL 160 MG cps 60x160mg KKA D
224.8 G04CX02 extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 1x denně) p.o. 1 DF 16,00 L/URN
59710 PROSTAMOL UNO cps 30x320mg BCE D
57894 SPALDA SABAL 320 MG cps 120x320mg KKA D
57895 SPALDA SABAL 320 MG cps 200x320mg KKA D
57893 SPALDA SABAL 320 MG cps 60x320mg KKA D
224.9 G04CX03 mepartricin p.o. 150 KU 20,00 L/URN
225 H01A hormony předního laloku hypofýzy parent.
--- --- --- --- --- --- --- ---
225.1 H01AA02 tetrakosaktid (nedepotní lékové formy) parent. 0.25 MG 59,93 L/END
225.2 H01AC01 somatropin parent. 2 U 660,39 L/J5
66752 GENOTROPIN 36 M.J.(12MG) inj pso Iqf 5x36ut PHA S
226 H01BA vasopresin a jeho deriváty parent.
--- --- --- --- --- --- --- ---
226.1 H01BA02 desmopresin parent. 4 RG 82,41 O
226.2 H01BA04 terlipresin (do 0,5 mg včetně v jedné ampuli) parent. 1 MG 288,08 H
226.3 H01BA04 terlipresin (nad 0,5 mg v jedné ampuli) parent. 1 MG 245,27 H
226.4 H01BA05 ornipresin parent. 5 U 27,57 H
227 H01BA vasopresin a jeho deriváty lok.
--- --- --- --- --- --- --- ---
227.1 H01BA02 desmopresin (nosní kapky) lok. 25 RG 22,89
227.2 H01BA02 desmopresin (nosní spray) lok. 25 RG 22,89
227.3 H01BA02 desmopresin (pevné lékové formy) p.o. 400 RG 22,89
228 H01BB oxytocin a jeho deriváty parent.
--- --- --- --- --- --- --- ---
228.1 H01BB02 oxytocin (do 2 U v jedné ampuli včetně) parent. 15 U 49,20 H
228.2 H01BB02 oxytocin (nad 2 U v jedné ampuli) parent. 15 U 21,96 H
229 H01CA hormon uvolňující gonadotrofin lok.
--- --- --- --- --- --- --- ---
229.1 H01CA01 gonadorelin (nasálně) lok. 1.2 MG 203,34 Z
229.2 H01CA02 nafarelin do 4 ml včetně v jednom balení (nasálně) lok. 0,4 MG 147,61 Z
45481 SYNAREL spr nas 1x4ml/30dav SEA POR
229.3 H01CA02 nafarelin nad 4 ml v jednom balení (nasálně) lok. 0,4 MG 116,04 Z
83795 SYNAREL spr nas 1x8ml/60dav SEA POR
229.4 H01CC01 ganirelix (antagonista gonadotropin releasing hormonu ) parent. 0,25 MG 1440,00 Z
229.5 H01CC02 cetrorelix s obsahem 0,25 mg v 1 ampuli parent. 0,25 MG 1440,00 Z
229.6 H01CC02 cetrorelix s obsahem 3 mg v 1 ampuli parent. 0,25 MG 600,30 Z
230 H01CB somatostatin a jeho deriváty parent.
--- --- --- --- --- --- --- ---
230.1 H01CB01 somatostatin parent. 6 MG 7688,40 X
66824 SOMATOSTATIN-UCB 3 MG inf pso Iqf 1x3mg UCB B
230.2 H01CB02 oktreotid parent. 1 MG 4000,00 H
230.3 H01CB02 oktreotid s podáváním 1x měsíčně s obsahem 10 mg parent. 357 RG 1276,70 X
230.4 H01CB02 oktreotid s podáváním 1x měsíčně s obsahem 20 mg parent. 714 RG 1557,00 X
230.5 H01CB02 oktreotid s podáváním 1x měsíčně s obsahem 30 mg parent. 1072 RG 1832,00 X
230.6 H01CB03 lantreotid s obsahem 30mg parent. 2,14 MG 1557,00 X
230.7 H01CB03 lantreotid s obsahem 60mg parent. 2,14 MG 1557,00 X
46342 SOMATULINE AUTOGEL 60 MG inj sol1x0.3ml/60mg BFN F
230.8 H01CB03 lantreotid s obsahem 90mg parent. 3,21 MG 1832,00 X
46341 SOMATULINE AUTOGEL 90 MG inj sol1x0.3ml/90mg BFN F
230.9 H01CB03 lantreotid s obsahem 120mg parent. 4,29 MG 2109,00 X
46343 SOMATULINE AUTOGEL 120 MG injsol1x0.5ml/120mg BFN F
231 H02AA mineralokortikoidy p.o.
--- --- --- --- --- --- --- ---
231.1 H02AA02 fludrokortison p.o. 0.1 MG 4,76
58644 FLUDROCORTISON SQUIBB tbl 100x0.1mg HAG D
232 H02AB glukokortikoidy p.o.
--- --- --- --- --- --- --- ---
232.1 H02AB01 betamethason p.o. 1.5 MG 3,42
232.2 H02AB02 dexamethason (4 mg v jedné tabletě a více) p.o. 1.5 MG 9,37
83994 FORTECORTIN 4 tbl 20x4mg MEC D
232.3 H02AB02 dexamethason (méně než 4 mg v jedné tabletě) p.o. 1.5 MG 3,42
232.4 H02AB04 methylprednisolon (do 8 mg v jedné tabletě včetně) p.o. 7.5 MG 3,42
232.5 H02AB04 methylprednisolon (nad 8 mg v jedné tabletě) p.o. 7.5 MG 4,79
86606 MEDROL 16 MG por tblnob50x16mg-b PPU B
232.6 H02AB07 prednison p.o. 10 MG 2,80
02963 PREDNISON 20 LÉČIVA tbl 20x20mg-blistr LEX CZ
00269 PREDNISON 5 LÉČIVA tbl 20x5mg LEX CZ
232.7 H02AB08 triamcinolon p.o. 7.5 MG 2,74
232.8 H02AB09 hydrokortison p.o. 30 MG 7,07
76205 HYDROCORTISON 10 MG JENAPHARM por tbl nob 20x10mg VJP D
232.9 H02AB10 kortison p.o. 37.5 MG 5,07
232.10 H02AB07 prednison (do 10 mg včetně) p.rect. 10 MG 17,30
232.11 H02AB07 prednison (nad 30 mg) p.rect. 10 MG 4,59
232.12 H02AB07 prednison (nad 10 do 30 mg včetně) p.rect. 10 MG 8,16
233 H02AB glukokortikoidy parent.
--- --- --- --- --- --- --- ---
233.1 H02AB mazipredon parent. 30 MG 17,79 O
233.2 H02AB01 betamethason (depotní lékové formy) parent. 0.4 MG 3,28 O
86187 DIPROPHOS inj 1x1ml SCH F
89870 DIPROPHOS inj 1x1ml SCH B
78257 DIPROPHOS inj 5x1ml SCH F
89869 DIPROPHOS inj 5x1ml SCH B
233.3 H02AB02 dexamethason (do 8 mg v jedné ampuli včetně) parent. 1.5 MG 1,99 O
01673 DEXAMED inj 100x2ml/8mg MOE CY
84090 DEXAMED inj 10x2ml/8mg MOE CY
46037 DEXONA inj 6x2ml 4mg/ml CAI IND
46038 DEXONA inj 8x6x2ml CAI IND
233.4 H02AB02 dexamethason (40 mg v jedné ampuli) parent. 1.5 MG 24,50 O
99479 FORTECORTIN MONO 40(AMPULE) inj 1x5ml/40mg MEC D
233.5 H02AB04 methylprednisolon (do 80 mg v jedné ampuli včetně) parent. 20 MG 31,90 O
09709 SOLU-MEDROL inj sic 1x40mg+1ml PAU B
233.6 H02AB04 methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) parent. 20 MG 22,11 O
09711 SOLU-MEDROL inj sic 500mg+7.8ml PAU B
233.7 H02AB04 methylprednisolon (nad 500 mg v jedné ampuli) parent. 20 MG 15,25 O
233.8 H02AB06 prednisolon (do 50 mg v jedné ampuli včetně) parent. 10 MG 17,46 O
233.9 H02AB06 prednisolon (nad 50 mg v jedné ampuli) parent. 10 MG 12,51 O
233.10 H02AB08 triamcinolon parent. 7.5 MG 13,64 O
233.11 H02AB09 hydrokortison parent. 30 MG 11,19 O
234 H03AA hormony štítné žlázy p.o.
--- --- --- --- --- --- --- ---
234.1 H03AA hormony štítné žlázy p.o. 1 DF 2,15
61161 JODTHYROX tbl 100 MEC D
61160 JODTHYROX tbl 50 MEC D
234.2 H03AA01 levothyroxin sodný (do 50 rg v 1 tabletě včetně) p.o. 0.15 MG 1,96
69189 EUTHYROX 50 tbl 100x50rg MEC D
47141 LETROX 50 tbl 100x50rg BCE D
234.3 H03AA01 levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) p.o. 0.15 MG 1,37
97186 EUTHYROX 100 tbl 100x100rg 97186 EUTHY
47144 LETROX 100 tbl 100x100rg BCE D
234.4 H03AA01 levothyroxin sodný (nad 100 rg v 1 tabletě) p.o. 0.15 MG 1,12
69191 EUTHYROX 150 tbl 100x150rg MEC D
47133 LETROX 150 tbl 100x150rg BCE D
234.5 H03AA02 liothyronin sodný p.o. 0.06 MG 4,40
234.6 H03AA03 kombinace levothyroxinu a liothyroninu p.o. 1 DF 1,81
03875 THYREOTOM tbl 60x50rg BCE D
234.7 H03CA jódová terapie p.o. 200 RG 1,81
61158 JODID 100 tbl 100 MEC D
61159 JODID 200 tbl 100 MEC D
235 H03B thyreostatika p.o.
--- --- --- --- --- --- --- ---
235.1 H03BA02 propylthiouracil p.o. 0.1 GM 7,04
09577 PROPYCIL 50 tbl 100x50mg SVP D
235.2 H03BB01 karbimazol p.o. 15 MG 2,91
00066 CARBIMAZOL-SLOVAKOFARMA tbl 100x5mg SLO SK
235.3 H03BB02 thiamazol p.o. 10 MG 2,83
235.4 H03BC01 perchlorát draselný p.o. 0.2 GM 1,66
236 H03B thyreostatika parent.
--- --- --- --- --- --- --- ---
236.1 H03BB02 thiamazol parent. 10 MG 4,50 H
237 H04AA glukagon a jeho deriváty parent.
--- --- --- --- --- --- --- ---
237.1 H04AA01 glukagon parent. 1 MG 404,62 L/DIA
237.2 H04AA01 glukagon (ve formě hypokit) parent. 1 MG 811,39 L/DIA
83741 GLUCAGEN 1 MG HYPOKIT inj sic 1mg+sol+stŘ NOO DK
238 H05BA kalcitonin inhal.
--- --- --- --- --- --- --- ---

Kalcitonin předepisuje internista,ortoped, gynekolog a endokrinolog:

u osteoporozy dokumentované denzitometricky (méně než -2,5 SD) nebo osteoporotické patologické zlomeniny pokud jsou tyto stavy spojené s výrazným algickým (bolestivým) syndromem, nereagujícím na běžnou analgetickou terapii.

Po 3.měsících je vyhodnocen efekt léčby. Pokud došlo k poklesu biochemických markerů (hodnocení kostní remodelace) a k ústupu algického syndromu, je možno pokračovat v další léčbě po dobu maximálně 6 měsíců.

Kalcitonin není lékem první volby u osteoporozy bez algického (bolestivého) syndromu.

Dále je indikován u: hyperkalcemické krize, Pagetova choroba s bolestmi v kostech,neurodystrofické stavy

| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 104,13 | P | | 30967 | OSTEODON 100 I.U. | sprnas1x3.5ml/28dÁv | LEX | CZ | | | | | 64662 | TONOCALCIN 100I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | | | | | 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 | U | 83,00 | P | | 30968 | OSTEODON 200 I.U. | sprnas1x2.1ml/14dÁv | LEX | CZ | | | | | 10146 | TONOCALCIN 200 I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | | | | | 239 | H05BA | kalcitonin | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,ORT, END,GER | | | | | | | | | | | 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,ORT, END,GER | | | | | | | | | | | 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,ORT, END,GER | | 240 | J01AA | tetracyklinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 3,92 | | | 97654 | DOXYBENE 100MG | cps 10x100mg | MCK | D | | | | | 04013 | DOXYBENE 200 MG TABLETY | por tbl nob10x200mg | MCK | D | | | | | 47718 | DOXYCYCLIN AL 100 | tbl 10x100mg | APA | D | | | | | 47719 | DOXYCYCLIN AL 100 | tbl 20x100mg | APA | D | | | | | 47720 | DOXYCYCLIN AL 200 | tbl 10x200mg | APA | D | | | | | 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | | | | | 12737 | DOXYHEXAL 200 TABS | tbl 10x200mg | SFS | D | | | | | 12738 | DOXYHEXAL 200 TABS | tbl 20x200mg | SFS | D | | | | | 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | | | | | 32953 | DOXYHEXAL TABS | tbl 10x100mg | SFS | D | | | | | 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | | | | | 32954 | DOXYHEXAL TABS | tbl 20x100mg | SFS | D | | | | | 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 3,92 | | | | | | | | | | | | 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 3,92 | | | | | | | | | | | | 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 3,92 | | | | | | | | | | | | 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 3,92 | | | | | | | | | | | | 240.6 | J01AA52 | doxycyklin v kombinaci s ambroxolem | p.o. | 1 | DF | 6,17 | | | 241 | J01AA | tetracyklinová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 91,28 | K | | 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | | | | | 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | | | | | 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K | | 242 | J01BA | amfenikolová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 25,88 | | | 71951 | CHLORAMPHENICOL LÉČIVA | cps 30x250mg | LEX | CZ | | | | | 243 | J01BA | amfenikolová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 267,93 | K | | | | | | | | | | | 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K | | 244 | J01CA | aminopenicilinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 14,13 | | | | | | | | | | | | 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 17,20 | | | | | | | | | | | | 244.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1tabletě včetně | p.o. | 1 | GM | 10,12 | | | 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | | | | | 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | | | | | 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | | | | | 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK | | | | | 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg | HHC | D | | | | | 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D | | | | | 62053 | DUOMOX 375 | tbl 20x375mg | YEU | NL | | | | | 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | | | | | 66364 | OSPAMOX 250MG | cps 12x250mg | BCA | A | | | | | 66368 | OSPAMOX 500 MG | por tbl flm12x500mg | BCA | A | | | | | 32557 | OSPAMOX 500 MG | por tbl flm14x500mg | BCA | A | | | | | 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1tabletě | p.o. | 1 | GM | 9,06 | | | 65929 | AMOXICILLIN AL 1000 | tbl obd 10x1000mg | APA | D | | | | | 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D | | | | | 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D | | | | | 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D | | | | | 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D | | | | | 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D | | | | | 44341 | AMOXIHEXAL 750 | tbl obd 50x750mg | HHC | D | | | | | 66370 | OSPAMOX 1000 MG | por tblflm12x1000mg | BCA | A | | | | | 32559 | OSPAMOX 1000 MG | por tblflm14x1000mg | BCA | A | | | | | 66369 | OSPAMOX 750 MG | por tbl flm12x750mg | BCA | A | | | | | 32558 | OSPAMOX 750 MG | por tbl flm 14x750mg | BCA | A | | | | | 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | | | 84510 | AMOCLEN 250 | sir sic 1x100ml/5gm | LEX | CZ | | | | | 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D | | | | | 44347 | AMOXIHEXAL FORTE | plv sus 1x100ml | AAG | D | | | | | 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | BCA | A | | | | | 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | BCA | A | | | | | 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1 | GM | 10,00 | | | 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | | | | | 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D | | | | | 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D | | | | | 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D | | | | | 244.7 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | | | 245 | J01CA | aminopenicilinová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,08 | K | | 246 | J01CA | acylureidová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 637,48 | U/ATB | | | | | | | | | | | 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB | | | | | | | | | | | 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB | | 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 247.1 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | | | 92434 | V-PENICILIN 0.4 MEGA BIOTIKA | por tbl nob30x400ku | BTA | SK | | | | | 92805 | V-PENICILIN 250 MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | | | 247.2 | J01CE02 | fenoxymethylpenicilin (od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | | | 56831 | OSPEN 500 | por tblflm12x500ku | BCA | A | | | | | 45996 | OSPEN 500 | por tblflm30x500ku | BCA | A | | | | | 92435 | V-PENICILIN 0.8 MEGA BIOTIKA | por tbl nob30x800ku | BTA | SK | | | | | 92805 | V-PENICILIN 250 MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | | | 247.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | | | 66359 | OSPEN 1000 | por tblflm12x1000ku | BCA | A | | | | | 45997 | OSPEN 1000 | por tblflm30x1000ku | BCA | A | | | | | 66360 | OSPEN 1500 | por tblflm12x1500ku | BCA | A | | | | | 45998 | OSPEN 1500 | por tblflm30x1500ku | BCA | A | | | | | 65356 | PENBENE 1 000 000 | tbl obd 12x1mu | MCK | D | | | | | 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D | | | | | 49513 | PENBENE 1 000 000 | tbl obd 30x1mu | MCK | D | | | | | 57778 | PENBENE 1 500 000 | tbl obd 21 | MCK | D | | | | | 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | | | | | 30069 | PENCID 1000 | tbl obd 30x1mu | LEX | CZ | | | | | 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ | | | | | 92436 | V-PENICILIN 1.2 MEGA BIOTIKA | por tbl nob30x1.2mu | BTA | SK | | | | | 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-bli | SLO | SK | | | | | 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-bli | SLO | SK | | | | | 247.4 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | | | | | | | | | | | | 247.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | | | | | | | | | | | | 247.6 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 15,05 | | | 56442 | PENCLEN | tbl 30x350mg-bli | SLO | SK | | | | | 247.7 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 29,43 | | | 49549 | OSPEN 400MG | sir 1x150ml | BCA | A | | | | | 76213 | OSPEN 750 KRKA | por sus 1x60ml/9gm | KRK | SLO | | | | | 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K | | 02136 | PENICILIN G 0.5 DRAS.SOL BIOT. | inj sic 10x500ku | BTA | SK | | | | | 01093 | PENICILIN G 1.0 DRAS.SOL BIOT. | inj sic 10x1mu | BTA | SK | | | | | 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K | | 93405 | PENICILIN G 5.0 DRAS.SOL BIOT. | inj sic 10x5mu | BTA | SK | | | | | 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K | | | | | | | | | | | 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 27,83 | K | | 01764 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCA | A | | | | | 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K | | | | | | | | | | | 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K | | 01102 | PROKAIN PENICILIN G 1.5 BIOTIKA | inj sic 10x1.5mu | BTA | SK | | | | | 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K | | 02723 | PENDEPON COMPOSITUM | inj sic 10x1.5mu | BTA | SK | | | | | 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | | | | | | | | | | | | 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | | | | | | | | | | | | 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | | | | | | | | | | | | 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | | | 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 95,80 | K | | 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 251.1 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | | | | | | | | | | | | 251.2 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | | | | | | | | | | | | 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | | | 85524 | AMOKSIKLAV 375MG | tbl obd 21x375mg | LEK | SLO | | | | | 86026 | AUGMENTIN 375 MG | tbl obd 21x375mg | SKW | GB | | | | | 86147 | AUGMENTIN 375 MG | tbl obd 21x375mg | LEX | CZ | | | | | 93709 | AUGMENTIN 375 MG | tbl obd 21x375mg | SKW | GB | | | | | 95213 | AUGMENTIN 375 MG | tbl obd 21x375mg | LEX | CZ | | | | | 46093 | ENHANCIN 250/125MG | tbl obd 21x250mg | RXY | IND | | | | | 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | | | 85525 | AMOKSIKLAV 625MG | tbl obd 21x625mg | LEK | SLO | | | | | 96459 | AMOXICILLIN-RATIOPH COMP.625 MG | por tbl flm21x625mg | MCK | D | | | | | 85446 | AUGMENTIN 625 MG | tbl obd 21x625mg | LEX | CZ | | | | | 86148 | AUGMENTIN 625 MG | tbl obd 21x625mg | SKW | GB | | | | | 86149 | AUGMENTIN 625 MG | tbl obd 21x625mg | LEX | CZ | | | | | 89852 | AUGMENTIN 625 MG | tbl obd 21x625mg | SKW | GB | | | | | 32389 | BETAKLAV | por tblnob21x625mg | KRK | SLO | | | | | 53577 | CURAM 625MG | tbl obd 21x625mg | BCA | A | | | | | 46094 | ENHANCIN 500/125MG | tbl obd 21x500mg | RXY | IND | | | | | 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | | | 05951 | AMOKSIKLAV 1G | tbl obd 14x1gm | LEA | SLO | | | | | 12494 | AUGMENTIN 1 G | tbl obd 14x1gm | SKW | GB | | | | | 94933 | AUGMENTIN 1 G | tbl obd 14x1gm | SKW | GB | | | | | 94934 | AUGMENTIN 1 G | tbl obd 14x1gm | LEX | CZ | | | | | 95137 | AUGMENTIN 1 G | tbl obd 14x1gm | LEX | CZ | | | | | 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | | | 74991 | AMOKSIKLAV | plv sus 1x100ml | LEK | SLO | | | | | 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A | | | | | 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 | | | 96416 | AMOKSIKLAV FORTE | plv sus 1x100ml | LEK | SLO | | | | | 94875 | AUGMENTIN DUO | por plv sus 1x140ml | LEX | CZ | | | | | 84792 | AUGMENTIN DUO | por plv sus 1x70ml | SKW | GB | | | | | 94873 | AUGMENTIN DUO | por plv sus 1x70ml | LEX | CZ | | | | | 53571 | CURAM 312.5MG/5ML | plv sus 1x100ml | BCA | A | | | | | 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2 | GM | 162,17 | U/ATB | | | | | | | | | | | 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 109,88 | U/ATB | | 32280 | AMOKSIKLAV 1.2 G | inj plv sol 5x1.2gm | LEA | SLO | | | | | 72972 | AMOKSIKLAV 1.2 G | inj plv sol 5x1.2gm | LEK | SLO | | | | | 32279 | AMOKSIKLAV 600 MG | inj plv sol 5x600mg | LEA | SLO | | | | | 72973 | AMOKSIKLAV 600 MG | inj plv sol 5x600mg | LEK | SLO | | | | | 94808 | AUGMENTIN 1.2 GM | inj sic 5x1.2gm | LEX | CZ | | | | | 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB | | | | | | | | | | | 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB | | | | | | | | | | | 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U | | | | | | | | | | | 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB | | 253 | J01DA | cefalosporinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | | | 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | | | | | 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | | | | | 06158 | ORACEF 500MG | cps 16x500mg | KRK | SLO | | | | | 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | | | | | 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | | | | | 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | | | 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | | | | | 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | | | | | 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | | | | | | | | | | | | 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | | | | | | | | | | | | 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 71,43 | | | 01665 | CEFACLOR 250-SL | cps 21x250mg | SLO | SK | | | | | 58765 | SERVICLOR 250 MG | cps 21x250mg | BCA | A | | | | | 53153 | VERCEF 250MG | cps 7x3(blistr) | RXY | IND | | | | | 47210 | VERCEF MR 375 MG | por tblret 14x375mg | RXY | IND | | | | | 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. 1.5 | GM | 66,03 | | | | 45193 | CEC 500 | tbl obd 10x500mg | SFS | D | | | | | 45194 | CEC 500 | tbl obd 20x500mg | SFS | D | | | | | 01667 | CEFACLOR 500-SL | cps 21x500mg | SLO | SK | | | | | 32156 | SERVICLOR 500 MG | cps 21x500mg | BCA | A | | | | | 53157 | VERCEF 500MG | cps 7x3-bli | RXY | IND | | | | | 253.7 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 | | | 45195 | CEC SIRUP | plv sus 100ml/2.5gm | SFS | D | | | | | 58763 | SERVICLOR 125 MG/5ML | por gra sus 1x100ml | BCA | A | | | | | 53151 | VERCEF 125MG/5ML | plv sus 1x100ml | RXY | IND | | | | | 253.8 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | | | 45196 | CEC FORTE SIRUP | plv sus 100ml/5gm | SFS | D | | | | | 66282 | CEFACLOR AL SUSP. | gra sus 1x100ml/5gm | APA | D | | | | | 58764 | SERVICLOR 250 MG/5ML | por gra sus 1x100ml | BCA | A | | | | | 53152 | VERCEF 250MG/5ML | plv sus 1x100ml | RXY | IND | | | | | 253.9 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 40,00 | | | 44799 | BIODROXIL | cps 12x500mg | BCA | A | | | | | 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A | | | | | 253.10 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 63,30 | | | | | | | | | | | | 253.11 | J01DA23 | cefixim | p.o. | 0.4 | GM | 107,35 | ATB | | | | | | | | | | | 253.12 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB | | | | | | | | | | | 253.13 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB | | | | | | | | | | | 253.14 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB | | | | | | | | | | | 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | | | | | | | | | | | | 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | | | 254 | J01DA | cefalosporinová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ceftriaxonem v ambulantní péči ordinuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog:

| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U/ATB | | 85512 | CEFALOTIN 1.0 BIOTIKA | inj sic 50x1gm | BTA | SK | | | | | 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 128,71 | U/ATB | | 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | | | | | 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F | | | | | 83111 | ORIZOLIN 1000 | inj sic 1x1000mg | CAI | IND | | | | | 91148 | VULMIZOLIN 1.0 | inj sic 10x1gm | BTA | SK | | | | | 85510 | VULMIZOLIN 1.0 | inj sic 50x1gm | BTA | SK | | | | | 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB | | | | | | | | | | | 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 439,20 | U/ATB | | 64833 | AXETINE 1.5GM | inj sic 100x1.5gm | MOE | CY | | | | | 64831 | AXETINE 1.5GM | inj sic 10x1.5gm | MOE | CY | | | | | 64837 | AXETINE 750 MG | inj sic 100x750mg | MOE | CY | | | | | 64835 | AXETINE 750 MG | inj sic 10x750mg | MOE | CY | | | | | 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB | | 99332 | MANDOL 1G | inj sic 1x1gm | LIL | I | | | | | 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 524,01 | U/ATB | | 94176 | CEFOTAXIME LEK 1 G | inj sic 1x1gm | LEK | SLO | | | | | 05770 | TAXCEF | inj sic 1x1gm | RXY | IND | | | | | 254.7 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 459,00 | U/ATB | | 05748 | TAXCEF 2G | inj sic 1x2gm | RXY | IND | | | | | 254.8 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB | | | | | | | | | | | 254.9 | J01DA11 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6 | GM | 1739,99 | U/ATB | | | | | | | | | | | 254.10 | J01DA12 | cefsulodin | parent. | 6 | GM | 615,68 | U/ATB | | | | | | | | | | | 254.11 | J01DA13 | ceftriaxon | parent. | 2 | GM | 555,00 | ambulantně: K/P ústavně: U/ATB | | 58756 | CEFTRIAXON TORREX 2 G | inj plv sol 1x2gm | TRX | A | | | | | 80662 | LENDACIN 1G | inj sic 5x1gm | LEK | SLO | | | | | 64638 | OFRAMAX 1 G | inj sic 1x1gm | RXY | IND | | | | | 254.12 | J01DA22 | ceftizoxim | parent. | 4 | GM | 615,68 | U/ATB | | | | | | | | | | | 254.13 | J01DA24 | cefepim | parent. | 4 | GM | 1605,91 | U/ATB | | | | | | | | | | | 254.14 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U/ATB | | | | | | | | | | | 254.15 | J01DA32 | cefoperazon | parent. | 6 | GM | 1526,24 | U/ATB | | | | | | | | | | | 254.16 | J01DA37 | cefpirom | parent. | 4 | GM | 1638,40 | U/ATB | | 255 | J01DF | monobaktámová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1645,60 | U/ATB | | 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 256.1 | J01DH | ertapenem | parent. | 1 | GM | 1980,00 | U/ATB | | 256.2 | J01DH02 | meropenem | parent. | 2 | GM | 2194,52 | U/ATB | | | | | | | | | | | 256.3 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2238,99 | U/ATB | | 12091 | TIENAM I.M.500 MG | inj sic 1x500/500mg | MSD | CH | | | | | 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 11,88 | | | 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D | | | | | 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D | | | | | 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 8,94 | | | 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D | | | | | 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D | | | | | 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | | | 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | | | | | | | | | | | | 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | | | 12917 | BISMORAL 480 | tbl 20x480mg | SLO | SK | | | | | 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D | | | | | 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D | | | | | 87758 | ORIPRIM | tbl 100x480mg | CAI | IND | | | | | 97868 | ORIPRIM | tbl 20x480mg | CAI | IND | | | | | 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | | | | | | | | | | | | 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | | | | | | | | | | 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | | | | | | | | | | | | 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | | | | | | | | | | 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | | | | | | | | | | | | 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 259.1 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 127,04 | K | | 260 | J01FA | makrolidová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 260.1 | J01FA | telithromycin | p.o. | 800 | MG | 96,80 | U/ATB | | | | | | | | | | | 260.2 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 19,09 | | | | | | | | | | | | 260.3 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 43,33 | | | 97508 | ERYTHROMYCIN-RATIOPHARM TS | plv sus 1x100ml | MCK | D | | | | | 55585 | MEROMYCIN | plv sus 1x100ml | MCK | D | | | | | 260.4 | J01FA02 | spiramycin | p.o. | 3 | GM | 42,75 | | | | | | | | | | | | 260.5 | J01FA05 | oleandomycin | p.o. | 1 | GM | 14,59 | | | | | | | | | | | | 260.6 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 38,67 | | | | | | | | | | | | 260.7 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 33,44 | | | 10855 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm10x150mg | MCK | D | | | | | 10857 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm14x150mg | MCK | D | | | | | 10875 | ROXITHROMYCIN-RATIOPHARM 300 MG | por tbl flm10x300mg | MCK | D | | | | | 260.8 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 30,08 | | | | | | | | | | | | 260.9 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 40,45 | | | | | | | | | | | | 260.10 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 42,75 | | | 53282 | FROMILID 250 | tbl obd 14x250mg | KRK | SLO | | | | | 53283 | FROMILID 500 | tbl obd 14x500mg | KRK | SLO | | | | | 03750 | LEKOKLAR 250 MG | por tbl flm14x250mg | LEK | SLO | | | | | 03751 | LEKOKLAR 500 MG | por tbl flm14x500mg | LEK | SLO | | | | | 260.11 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 66,50 | | | 58491 | FROMILID | por gra sus 1x60ml | KRK | SLO | | | | | 260.12 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 56,34 | | | | | | | | | | | | 260.13 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 55,86 | | | 10380 | AZITROX 250 | por tbl flm 3x250mg | LEX | CZ | | | | | 10381 | AZITROX 250 | por tbl flm 6x250mg | LEX | CZ | | | | | 10382 | AZITROX 500 | por tbl flm 3x500mg | LEX | CZ | | | | | 260.14 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 82,27 | | | | | | | | | | | | 260.15 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 42,75 | | | | | | | | | | | | 260.16 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,16 | | | 261 | J01FA | makrolidová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 717,50 | K | | | | | | | | | | | 261.2 | J01FA02 | spiramycin | parent. | 4,5 | MU | 663,67 | K | | 78174 | ROVAMYCINE PLV.PRO INF.1.5 MIU | plv inf 1x1.5mu | RSL | F | | | | | 261.3 | J01FA09 | klaritromycin | parent. | 1 | GM | 861,00 | K | | | | | | | | | | | 261.4 | J01FA10 | azitromycin | parent. | 0,5 | GM | 474,33 | K | | 262 | J01FF | linkosamidová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 55,46 | | | 03365 | DALACIN C 150MG | cps 16x150mg | PAU | B | | | | | 83458 | DALACIN C 300MG | cps 16x300mg | PAU | B | | | | | 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 136,53 | | | | | | | | | | | | 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB | | 91997 | NELOREN | cps 16x500mg | LEK | SLO | | | | | 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 160,62 | ATB | | 263 | J01FF | linkosamidová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 263.1 | J01FF01 | klindamycin (do 0,3 gm včetně v jedné ampuli) | parent. | 1.8 | GM | 598,67 | U/ATB | | | | | | | | | | | 263.2 | J01FF01 | klindamycin (nad 0,3 gm v jedné ampuli) | parent. | 1.8 | GM | 548,92 | U/ATB | | | | | | | | | | | 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 49,17 | U/ATB | | | | | | | | | | | 263.4 | J01FG02 | quinupristin v kombinaci s dalfopristinem | parent | 1 | DF | 2492,00 | U/ATB | | 264 | J01GA | streptomycin a jeho deriváty | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 117,10 | | | 265 | J01GB | aminoglykosidová antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43,84 | U/ATB | | | | | | | | | | | 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,02 | U/ATB | | | | | | | | | | | 265.3 | J01GB01 | tobramycin (léková forma – inhalační roztok) | inhal. | 0.6 | GM | 2975,00 | P |

Tobramycin v inhalační formě je indikován pacientům s cystickou fibrózou infikovaných Pseudomonas aeruginosa, starších 6-ti let.

265.4 J01GB03 gentamicin (do 40 mg v jedné ampuli včetně) parent. 0.24 GM 45,18 U/ATB
265.5 J01GB03 gentamicin (nad 40 mg v jedné ampuli) parent. 0.24 GM 23,61 U/ATB
265.6 J01GB03 gentamicin (lékové formy pěny) lok. 130 MG 2411,98 U/ATB
265.7 J01GB03 gentamicin (lékové formy kuliček k implantaci) imp. 1 DF 152,06 U/ATB
265.8 J01GB05 neomycin parent. 1 GM 122,34 U/ATB
265.9 J01GB06 amikacin (do 100 mg v jedné ampuli včetně) parent. 1 GM 741,01 U/ATB
265.10 J01GB06 amikacin (nad 100 mg v jedné ampuli) parent. 1 GM 398,66 U/ATB
265.11 J01GB07 netilmicin (do 50 mg v jedné ampuli včetně) parent. 0.35 GM 519,93 U/ATB
265.12 J01GB07 netilmicin (nad 50 mg v jedné ampuli) parent. 0.35 GM 304,57 U/ATB
265.13 J01GB11 isepamicin (do 250 mg včetně v jedné ampuli) parent. 1 GM 620,27 U/ATB
265.14 J01GB11 isepamicin (nad 250 mg v jedné ampuli) parent. 1 GM 516,90 U/ATB
266 J01MA fluorované chinolony p.o.
--- --- --- --- --- --- --- ---

K léčbě sparfloxacinem a trovafloxacinem je třeba konzultace a schválení antibiotického střediska.

| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 24,50 | | | 12349 | ZANOCIN 200MG | tbl obd 10x200mg | RXY | IND | | | | | 266.2 | J01MA02 | ciprofloxacin | p.o. | 1 | GM | 24,50 | | | 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ | | | | | 53715 | CIFLOXINAL | tbl obd 200x250mg | PMP | CZ | | | | | 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ | | | | | 64825 | CIFRAN 250 MG | tbl obd 10x250mg | RXS | IND | | | | | 64827 | CIFRAN 500 MG | tbl obd 10x500mg | RXS | IND | | | | | 53201 | CIPHIN 250 | tbl obd 10x250mg | SLO | SK | | | | | 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK | | | | | 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND | | | | | 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND | | | | | 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND | | | | | 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND | | | | | 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO | | | | | 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO | | | | | 69195 | CIPROBID 250 | tbl obd 10x250mg | CAI | IND | | | | | 69196 | CIPROBID 500 | tbl obd 10x500mg | CAI | IND | | | | | 266.3 | J01MA03 | pefloxacin | p.o. | 0.8 | GM | 24,50 | | | 94156 | ABAKTAL | tbl obd 10x400mg | LEK | SLO | | | | | 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 20,50 | | | | | | | | | | | | 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 20,50 | | | 44090 | GYRABLOCK 400 | por tblflm500x400mg | MOE | CY | | | | | 44091 | GYRABLOCK 400 | portblflm1000x400mg | MOE | CY | | | | | 93465 | NOLICIN | tbl obd 20x400mg | KRK | SLO | | | | | 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 24,50 | | | | | | | | | | | | 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 24,50 | | | | | | | | | | | | 266.8 | J01MA09 | sparfloxacin | p.o. | 0.2 | GM | 24,50 | P | | | | | | | | | | | 266.9 | J01MA12 | levofloxacin do 250 mg v jedné tabletě včetně | p.o. | 0,25 | GM | 75,00 | U/ATB | | | | | | | | | | | 266.10 | J01MA12 | levofloxacin nad 250 mg v jedné tabletě | p.o. | 0,25 | GM | 60,00 | U/ATB | | | | | | | | | | | 266.11 | J01MA14 | moxifloxacin | p.o. | 0,4 | GM | 60,00 | U/ATB | | | | | | | | | | | 266.12 | J01MA | trovafloxacin | p.o. | 0,2 | GM | 24,50 | P | | | | | | | | | | | 266.13 | J01MB05 | kyselina oxolinová | p.o. | 1 | GM | 8,91 | | | 91101 | DESUROL | tbl 50x250mg | LEX | CZ | | | | | 267 | J01MA | fluorované chinolony | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 267.1 | J01MA01 | ofloxacin | parent. | 0.4 | GM | 212,23 | U/ATB | | 66137 | OFLOXIN INF | inf 1x100ml/200mg | LEX | CZ | | | | | 267.2 | J01MA02 | ciprofloxacin – infúze | parent. | 0.5 | GM | 212,23 | U/ATB | | 59829 | CIPRINOL 100MG/50ML | inf 1x50ml/100mg | KRK | SLO | | | | | 59830 | CIPRINOL 200MG/100ML | inf 1x100ml/200mg | KRK | SLO | | | | | 267.3 | J01MA02 | ciprofloxacin – injekce | parent. | 0.5 | GM | 190,00 | U/ATB | | | | | | | | | | | 267.4 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 93,26 | U/ATB | | 94155 | ABAKTAL | inj 10x5ml/400mg | LEK | SLO | | | | | 267.5 | J01MA08 | fleroxacin | parent. | 0.4 | GM | 212,23 | U/ATB | | | | | | | | | | | 267.6 | J01MA12 | levofloxacin | parent | 0,25 | GM | 477,00 | U/ATB | | | | | | | | | | | 267.7 | J01MA | trovafloxacin | parent. | 0,2 | GM | 212,23 | U/ATB | | 268 | J01XA | ostatní antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1265,30 | U/ATB | | 92289 | EDICIN 0.5 GM | inj plv sol 1x500mg | LEK | SLO | | | | | 92290 | EDICIN 1GM | inj plv sol 1x1gm | LEK | SLO | | | | | 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 2492,83 | U/ATB | | | | | | | | | | | 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 109,34 | U/ATB | | 61178 | COLIMYCINE | inj sic 50x1mu | RDG | GB | | | | | 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 103,09 | U/ATB | | | | | | | | | | | 268.5 | J01XX08 | linezolid | p.o. | 1,2 | GM | 4958,00 | U/ATB | | | | | | | | | | | 268.6 | J01XX08 | linezolid | parent | 1,2 | GM | 4958,00 | U/ATB | | 269 | J01XB | polymyxinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 269.1 | J01XB01 | kolistin | p.o. | 3 | MU | 42,82 | U/ATB | | 270 | J01XD | imidazolová chemoterapeutika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 270.1 | J01XD01 | metronidazol | parent. | 1.5 | GM | 176,89 | U | | | | | | | | | | | 270.2 | J01XD03 | ornidazol | parent. | 1 | GM | 50,44 | U | | | | | | | | | | | 270.3 | J01XE01 | nitrofurantoin | p.o. | 0.2 | GM | 3,65 | | | 90510 | FURANTOIN LÉČIVA TBL FLM | por tbl ent20x100mg | LEX | CZ | | | | | 271 | J02AA | antimykotická antibiotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 279,36 | U | | 57548 | AMPHOTERICIN B SQUIBB | inj sic 1x50mg | BMJ | F | | | | | 271.2 | J02AA01 | amfotericin na tukových nosičích | parent. | 35 | MG | 1597,70 | U/ATB | | 272 | J02AB | imidazolová antimykotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 272.1 | J02AB02 | ketokonazol | p.o. | 0.2 | GM | 25,00 | | | 91739 | ORONAZOL | tbl 20x200mg | KRK | SLO | | | | | 273 | J02AB | imidazolová antimykotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 273.1 | J02AB01 | mikonazol | parent. | 1 | GM | 469,63 | U | | 274 | J02AC | triazolová antimykotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

• postižení celé nehtové ploténky

• postižení minimálně čtyř nehtových plotének tak, že každá z nich má postižení zasahující více než 30% za volný okraj nehtu proximálním směrem

• postižení nehtu palce dolní končetiny

Podmínkou zahájení léčby ad c) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.

| 274.1 | J02AC01 | flukonazol ( pevné lékové formy 150 mg v 1 tabletě ) | p.o. | 0.15 | GM | 203,85 | P | | 59788 | DIFLAZON 150 | cps 1x150mg | KRK | SLO | | | | | 53917 | FLUCONAZOL 150-SLOVAKOFARMA | cps 1x150mg | SLO | SK | | | | | 10689 | FORCAN - 150 | por cps dur 1x150mg | CIA | IND | | | | | 66039 | MYCOMAX 150 | por cps dur 1x150mg | LEX | CZ | | | | | 47439 | MYCOMAX 150 | por cps dur 3x150mg | LEX | CZ | | | | | 59875 | MYCOSYST 150 MG | cps 1x150mg | GED | H | | | | | 59876 | MYCOSYST 150 MG | cps 2x150mg | GED | H | | | | | 10743 | MYCOSYST 150 MG | cps 4x150mg | GED | H | | | | | 274.2 | J02AC01 | flukonazol – ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.2 | GM | 262,18 | P | | 59787 | DIFLAZON 100 | cps 28x100mg | KRK | SLO | | | | | 59790 | DIFLAZON 200 | cps 20x200mg | KRK | SLO | | | | | 59789 | DIFLAZON 200 | cps 7x200mg | KRK | SLO | | | | | 59786 | DIFLAZON 50 | cps 7x50mg | KRK | SLO | | | | | 55397 | FLUCONAZOL 50-SLOVAKOFARMA | cps 14x50mg | SLO | SK | | | | | 55396 | FLUCONAZOL 50-SLOVAKOFARMA | cps 7x50mg | SLO | SK | | | | | 30084 | FORCAN - 50 | por cps dur 7x50mg | CIA | IND | | | | | 66036 | MYCOMAX 100 | cps 28x100mg | LEX | CZ | | | | | 66037 | MYCOMAX 100 | cps 7x100mg | LEX | CZ | | | | | 66033 | MYCOMAX 50 | cps 28x50mg | LEX | CZ | | | | | 66032 | MYCOMAX 50 | cps 7x50mg | LEX | CZ | | | | | 274.3 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 479,01 | P | | 64950 | DIFLUCAN 50MG/5ML | plv sus 1x35ml | PFC | F | | | | | 66031 | MYCOMAX SIR | sir 1x100ml/500mg | LEX | CZ | | | | | 274.4 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 436,59 | P | | | | | | | | | | | 274.5 | J02AC01 | flukonazol – tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.2 | GM | 349,25 | P | | | | | | | | | | | 274.6 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.2 | GM | 95,60 | P | | | | | | | | | | | 274.7 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.2 | GM | 114,00 | P | | | | | | | | | | | 274.8 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 391,27 | P | | 56067 | SPORANOX | sol 1x150ml/1.5gm | JAN | B | | | | | 274.9 | J02AC03 | vorikonazol | p.o. | 0.4 | GM | 2.665,50 | U/ATB | | | | | | | | | | | 274.10 | J02AX01 | flucytosin | p.o. | 10 | GM | 858,22 | P | | 275 | J02AC | triazolová antimykotika | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Terapeuticky: těžké, život ohrožující systémové mykózy.

Profylakticky: u imunokomprimovaných pacientů nebo pacientů připravovaných k transplantaci.

275.1 J02AC03 vorikonazol parent. 0.4 GM 9.857,80 U/ATB
275.2 J02AC01 flukonazol parent. 0.2 GM 550,00 U/P
58431 DIFLAZON inf sol 1x100ml KRK SLO
46979 FLUCONAZOL-SLOVAKOFARMA PRO INF inf 1x100ml/200mg SLO SK
65989 MYCOMAX INF inf 1x100ml/200mg LEX CZ
275.3 J02AC02 itrakonazol parent. 0.2 GM 3.520,00 U/ATB
275.4 J02AX01 flucytosin parent. 10 GM 2710,83 U/P
275.5 J02AX04 caspofungin s obsahem 50 mg v jedné ampulce parent. 1 DF 17259,00 U/ATB
275.6 J02AX04 caspofungin s obsahem 70 mg v jedné ampulce parent. 1 DF 24163,00 U/ATB
276 J04AB antibiotika k léčbě tuberkulózy p.o.
--- --- --- --- --- --- --- ---

Léčbu rifabutinem ordinuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.

| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 12,76 | | | 96780 | ARFICIN 300 MG | cps 100x300mg | BLU | CHO | | | | | 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 125,72 | P | | 91946 | MYCOBUTIN 150 | cps 30x150mg | PHA | I | | | | | 277 | J04AB | antibiotika k léčbě tuberkulózy | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 244,40 | | | | | | | | | | | | 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 553,11 | | | 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 2,04 | | | 279 | J04AK | další léčiva k léčbě tuberkulózy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 14,63 | | | 75508 | TISAMID | tbl 100x500mg | ORN | SF | | | | | 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,22 | | | 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,37 | | | 91888 | DISULONE 100MG | tbl 100x100mg+200mg | LVN | F | | | | | 281 | J05A | antivirotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu brivudinem, acyklovirem, famcyklovirem a valaciklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog, klinický imunolog, neurolog a specialista pracující na transplantačních jednotkách:

Léčbu acyklovirem u pacientů s herpes zoster indikuje ošetřující lékař též odbornosti praktický lékař pro dospělé a praktický lékař pro děti a dorost.

Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.

Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinavir, lamivudin a abacavir) indikuje infekcionista pracující v AIDS centrech.

Léčbu lamivudinem dále indikuje ošetřující lékař u chronické virové hepatitidy typu B.

Léčbu gancyklovirem a valganciclovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:

281.1 J05AB brivudin p.o. 0.5 GM 458,88 P
281.2 J05AB01 acyklovir do 200 mg včetně p.o. 4 GM 272,00 P
57068 ACICLOVIRAL 200 tbl 25x200mg APA D
84127 HERPESIN 200 tbl 25x200mg PVL CZ
54031 PROVIRSAN tbl 30x200mg PMP CZ
54213 RANVIR 200 tbl 25x200mg RXG IND
53608 XOROX 200MG tbl 25x200mg KWI A
281.3 J05AB01 acyklovir nad 200 mg p.o. 4 GM 225,30 P
56079 ACICLOVIR AL 400 tbl 35x400mg APA D
54216 RANVIR 400 tbl 25x400mg RXG IND
53610 XOROX 400MG tbl 60x400mg KWI A
53611 XOROX 800MG tbl 35x800mg KWI A
281.4 J05AB04 ribavirin p.o. 1 GM 604,96 X
58274 REBETOL 200 MG por cpsdur168x200mg SCH B
281.5 J05AB06 gancyklovir p.o. 3 GM 1960,07 P
59653 CYMEVENE 250 MG por cpsdur84x250mg RPE GB
281.6 J05AB09 famcyklovir p.o. 0.75 GM 458,88 P
281.7 J05AB11 valacyklovir p.o. 3 GM 374,00 P
281.8 J05AB14 valgancyklovir p.o. 0,9 GM 2000,00 P
97249 VALCYTE 450 MG por tbl flm60x450mg HLR D
281.9 J05AE01 saquinavir p.o. 1,8 GM 453,70 P
59463 FORTOVASE 200 MG cps 180x200mg HLR D
281.10 J05AE02 indinavir p.o. 2,4 GM 453,70 P
281.11 J05AE03 ritonavir p.o. 1,2 GM 453,70 P
02940 NORVIR cps 2x84=168x100mg ABB GB
281.12 J05AE04 nelfinavir p.o. 2,25 GM 453,70 P
281.13 J05AE inhibitory proteáz (lopinavir,ritonavir v kombinaci) p.o. 6 DF 564,00 P
281.14 J05AF01 zidovudin p.o. 1.5 GM 685,28 P
281.15 J05AF02 didanosin p.o. 0.4 GM 236,43 P
281.16 J05AF03 zalcitabin p.o. 2.25 MG 235,25 P
66733 HIVID 0.375 MG tblobd100x0.375mg-b HLR CH
66734 HIVID 0.75 MG tblobd100x0.75mg-b HLR CH
281.17 J05AF04 stavudin p.o. 80 MG 302,07 P
53209 ZERIT 40 MG cps 56x40mg BMS F
281.18 J05AF05 lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně p.o. 0,3 GM 292,03 P
02085 ZEFFIX 100 MG tbl obd 28x100mg GOW GB
02086 ZEFFIX 100 MG tbl obd 84x100mg GOW GB
02087 ZEFFIX 5MG/ML sol 1x240ml/1.2g GWL GB
94802 ZEFFIX 5MG/ML sol 1x240ml/1.2g GWE D
281.19 J05AF05 lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru p.o. 0,3 GM 248,01 P
281.20 J05AF06 abacavir p.o. 600 MG 360,00 P
281.21 J05AF30 abacavir, lamivudin a zidovudin v kombinaci p.o. 2 DF 852,04 P
30158 TRIZIVIR por tbl flm 60 GOW GB
281.22 J05AF30 jiné kombinace antiretrovirových virostatik (lamivudin a zidovudin) p.o. 2 DF 522,13 P
281.23 J05AG01 nevirapin p.o. 0,4 GM 343,34 P
281.24 J05AG03 efavirenz p.o. 0,6 GM 431,00 P
281.25 J05AH01 zanamivir inhal. 20 MG 130,00 P

Zanamivir je indikován pro léčbu influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkováni proti influenze nebo tam, kde očkování selhalo, u následujících skupin pacientů:

Z veřejného zdravotního pojištění je pro jednu terapeutickou kůru hrazeno jedno balení určené k pětidenní léčbě. Zanamivir u výše uvedených skupin ordinuje ošetřující lékař pouze v době chřipkové epidemie vyhlášené krajskou hygienickou stanicí.

281.26 J05AH02 oseltamivir p.o. 150 MG 130,00 P

Oseltamivir je indikován pro léčbu influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkování proti influenze nebo tam, kde očkování selhalo, u následujících skupin pacientů:

Z veřejného zdravotního pojištění je pro jednu terapeutickou kůru hrazeno jedno balení určené k pětidenní léčbě. Oseltamivir u výše uvedených skupin ordinuje ošetřující lékař pouze v době chřipkové epidemie vyhlášené krajskou hygienickou stanicí.

| 281.27 | J05AX05 | inosin pranobex | p.o. | 1 | GM | 30,55 | P | | 88174 | ISOPRINOSINE | tbl 50x500mg | EWO | CH | | | | | 282 | J05AB | antivirotika ze skupiny nukloeosidů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu brivudinem, acyklovirem, famcyklovirem a valaciklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog, klinický imunolog, neurolog a specialista pracující na transplantačních jednotkách:

Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.

Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinavir a lamivudin) indikuje infekcionista pracující v AIDS centrech.

Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:

| 282.1 | J05AB01 | acyklovir | parent. | 4 | GM | 1551,47 | U/P | | 93260 | HERPESIN 250 | inf sic 10x250mg | PVL | CZ | | | | | 53607 | XOROX 250MG | inf sic 5x250mg | KWI | A | | | | | 282.2 | J05AB06 | gancyklovir | parent. | 0.5 | GM | 1568,70 | U/P | | 02064 | CYMEVENE | inf sic 1x500mg | HLR | CH | | | | | 282.3 | J05AB12 | cidofovir | parent. | 375 | MG | 33556,50 | U/P | | | | | | | | | | | 282.4 | J05AD01 | foskarnet | parent. | 6.5 | GM | 3006,25 | U/P | | | | | | | | | | | 282.5 | J05AF01 | zidovudin | parent. | 1 | GM | 2748,47 | U/P | | 283 | J06AA | imunitní séra | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Sérum proti stafylokokovým infekcím ordinuje lékař ke komplexní léčbě těžkých stafylokokových infekcí.

Sérum proti záškrtu ordinuje infekcionista nebo pediatr ke komplexní léčbě záškrtu.

Sérum proti hadímu jedu ordinuje lékař k léčbě uštknutí zmijí obecnou.

Sérum proti botulismu ordinuje lékař ke komplexní léčbě botulismu.

Sérum proti plynaté sněti ordinuje infekcionista nebo specialista chirurgických oborů k profylaxi a terapii klostridiových infekcí.

Sérum proti vzteklině ordinuje infekcionista k profylaxi nebo terapii vztekliny.

283.1 J06AA sérum proti stafylokokovým infekcím parent. plně K/P
283.2 J06AA01 sérum proti záškrtu parent. plně K/P
283.3 J06AA03 sérum proti hadímu jedu parent. plně K/P
93005 VIPER VENOM ANTITOXIN inj 1x5ml/500ut BIM PL
283.4 J06AA04 sérum proti botulinu parent. plně K/P
01190 BOSEA inj 1x35ml SVF CZ
283.5 J06AA05 sérum proti plynaté sněti parent. plně K/P
01195 GASEA inj 1x20ml/25ku SVF CZ
283.6 J06AA06 sérum proti vzteklině parent. plně K/P
46295 FAVIRAB inj 1x5ml/1ku AVS F
284 J06BA imunoglobuliny, normální lidské parent.
--- --- --- --- --- --- --- ---
284.1 J06BA01 imunoglobuliny, norm. lidské, k extravasální aplikaci do velikosti méně než 5 ml v jedné ampuli parent. 1 DF 245,80 O
57669 PASTEUR.HUM.IMMUNOGL.GRIFOLS 16 inj 1x2ml/320mg GFO E
284.2 J06BA01 imunoglobuliny, norm. lidské, k extravasální aplikaci 5 ml a více v jedné ampuli parent. 1 DF 600,00 O
284.3 J06BA02 imunoglobuliny normální lidské pro i.v. aplikaci parent. 1 GM 956,88 B
62554 INTRAGLOBIN F inf 1x100ml BTP D
62555 INTRAGLOBIN F inf 1x200ml BTP D
62553 INTRAGLOBIN F inf 1x50ml BTP D
284.4 J06BA02 imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) parent. 1 GM 1955,16 U
284.5 J06BA imunoglobuliny, norm. lidské ( k extravasální aplikaci), kombinace s histaminem parent. 1 DF 89,40 O
87736 HISTAGLOBIN inj 3x12mg+sol. BBL CH
285 J06BB specifické imunoglobuliny parent.
--- --- --- --- --- --- --- ---

Léčbu imunoglobuliny proti neštovicím a pásovému oparu ordinuje infekcionista, onkolog, hematolog a pediatr:

Léčbu imunoglobulinem proti cytomegalovirové infekci ordinuje infekcionista, onkolog, hematolog nebo pediatr:

Imunoglobulin proti tetanu je hrazen dle symbolu B.

| 285.1 | J06BB12 | protiencefalický globulin | parent. | 1 | ML | 300,65 | K | | 95082 | FSME-BULIN | inj 1x1ml | BXG | A | | | | | 95083 | FSME-BULIN | inj 1x2ml | BXG | A | | | | | 95084 | FSME-BULIN | inj 1x5ml | BXG | A | | | | | 285.2 | J06BB01 | anti-d (rh) imunoglobulin (do 100 rg v jedné ampuli včetně) | parent. | 250 | RG | 1407,96 | K | | | | | | | | | | | 285.3 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 rg v jedné ampuli) | parent. | 250 | RG | 1320,40 | K | | 57573 | PARTOBULIN S/D | inj 1x1ml/250rg | BXG | A | | | | | 285.4 | J06BB02 | imunoglobulin proti tetanu | parent. | | | plně | B | | 57804 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x1ml/250ut-str | GFO | E | | | | | 57805 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x2ml/500ut-str | GFO | E | | | | | 44668 | PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x250ut+2ml | GFO | E | | | | | 44669 | PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x500ut+2ml | GFO | E | | | | | 83607 | TETABULIN S/D | injsol1x1ml/250ut+s | BXG | A | | | | | 285.5 | J06BB03 | imunoglobulin proti neštovícím a pásovému oparu | parent. | 1 | KU | 32724,00 | K/P | | 97895 | VARITECT | inj 1x20ml/500ut | BTP | D | | | | | 97896 | VARITECT | inj 1x50ml/1.25ku | BTP | D | | | | | 97894 | VARITECT | inj 1x5ml/125ut | BTP | D | | | | | 285.6 | J06BB04 | imunoglobulin proti hepatitidě B | parent. | | | plně | K | | 97898 | HEPATECT | inj 1x10ml | BTP | D | | | | | 97897 | HEPATECT | inj 1x2ml | BTP | D | | | | | 57419 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x3ml/600ut | GFO | E | | | | | 57420 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x5ml/1000ut | GFO | E | | | | | 285.7 | J06BB05 | imunoglobulin proti rabies | parent. | | | plně | K/P | | 46731 | IMOGAM RABIES PASTEURIZED | inj 1x10ml/1500ut | AVS | F | | | | | 53163 | IMOGAM RABIES PASTEURIZED | inj 1x2ml/300ut | AVS | F | | | | | 285.8 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1 | GM | 4817,20 | U/P | | 94862 | CYTOTECT BIOTEST | inf sol 1x10ml-amp | BTP | D | | | | | 94863 | CYTOTECT BIOTEST | inf sol 1x20ml-amp | BTP | D | | | | | 94864 | CYTOTECT BIOTEST | inf sol 1x50ml-lah | BTP | D | | | | | 285.9 | J06BB16 | palivizumab do 50 mg v jedné ampuli včetně | parent | 1 | DF | 27.645 | X | | 02106 | SYNAGIS 50 MG | inj sic 1x50mg+sol | ABB | I | | | | | 285.10 | J06BB16 | palivizumab nad 50 mg v jedné ampuli | parent. | 1 | DF | 45.568,00 | X | | 02143 | SYNAGIS 100 MG | inj sic 1x100mg+sol | ABB | I | | | | | 286 | J07AM | očkovací látky proti tetanu | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 286.1 | J07AM01 | tetanový toxoid | parent. | | | plně | K | | 83622 | ALTEANA | inj 10x0.5ml/40ut | SVF | CZ | | | | | 83526 | TETAVAX | inj 10x10ml-lahv. | AVS | F | | | | | 83447 | TETAVAX | inj 10x20ml-lahv. | AVS | F | | | | | 83443 | TETAVAX | inj 1x0.5ml-stŘ. | AVS | F | | | | | 83445 | TETAVAX | inj 1x10ml-lahv. | AVS | F | | | | | 83525 | TETAVAX | inj 20x0.5ml-amp. | AVS | F | | | | | 83444 | TETAVAX | inj 20x0.5ml-stŘ. | AVS | F | | | | | 287 | J07AN | očkovací látky proti tuberkulóze | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 229,40 | H | | 58227 | BCG VACCINE SSI | inj sic 10x10dÁv+so | SST | DK | | | | | 58228 | BCG VACCINE SSI | inj sic 10x20dÁv+so | SST | DK | | | | | 288 | J07AX | jiné bakteriální očkovací látky | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 288.1 | J07AX | jiné bakteriální vakcíny (protistafylokoková vakcína) | parent. | | | plně | K | | 94269 | POLYSTAFANA | inj 10x0.5ml/5.4ut | SVF | CZ | | | | | 288.2 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1 | DF | 26,15 | K | | | | | | | | | | | 288.3 | J07AX | jiné bakteriální vakcíny (protipseudomo-nádová vakcína) | parent. | 1 | DF | 206,02 | O | | | | | | | | | | | 288.4 | J07AX | jiné bakteriální vakcíny (uropatogenní vakcína) | parent. | 1 | DF | 280,47 | O |

Vybrané vakcíny se podávají u splenektomovaných pacientů po nebo před výkonem a u pacientů po transplantaci krvetvorných buněk.

Meningokokus, bivalentni polysacharidový antigen se podává po nebo před výkonem u splenektomovaných pacientů.

Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.

Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla. e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)